Published in Drug Week, September 29th, 2006
In a recently published study, investigators in Australia conducted a study "to document the incidence of immediate and delayed adverse events (AE) following intravenous immunoglobulin (IVIG) infusion in children. Immediate and delayed adverse events were prospectively recorded for 345 infusions in 58 children receiving IVIG for immunodeficiency (n=33) or immunomodulation (n=25). For each infusion adverse events were documented during the infusion and by follow up interview 4 -7 days later."
"Immediate adverse events occurred in 10.3%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.